10
Participants
Start Date
February 20, 2024
Primary Completion Date
March 28, 2025
Study Completion Date
July 31, 2025
Glucagon
Glucagon infusion of 5 ng·kg-1·min-1 from 0-60 minutes and 10 ng·kg-1 ·min-1 from 60-120 minutes.
Placebo
Placebo (0.9% NaCl).
Glucagon and exendin 9-39
Glucagon (infusion of 5 ng·kg-1·min-1 from 0-60 minutes) and glucagon (infusion of 10 ng·kg-1 ·min-1 from 60-120 minutes) + a GLP-1R antagonist, exendin 9-39 (900 pmol·kg-1·min-1 from -30-120 minutes).
RECRUITING
Physiological laboratory, Bispebjerg Hospital, Research Unit, Clinical Physiology / Nuclear Medicine Department, Copenhagen
University of Copenhagen
OTHER
The Augustinus Foundation, Denmark.
OTHER
The Novo Nordic Foundation
OTHER
Ali Asmar
OTHER